Global Hepatitis B Vaccine (Recombinant) Market Insights and Forecast to 2028

Global Hepatitis B Vaccine (Recombinant) Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Hepatitis B Vaccine (Recombinant) Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mcg/0.5ml
1.2.3 10mcg/ml
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccine (Recombinant) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccine (Recombinant) Sales by Region
2.4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccine (Recombinant) by Region (2023-2028)
2.5 Global Hepatitis B Vaccine (Recombinant) Revenue by Region
2.5.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccine (Recombinant) Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccine (Recombinant) in 2021
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccine (Recombinant) Revenue in 2021
3.3 Global Hepatitis B Vaccine (Recombinant) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccine (Recombinant) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Type
4.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Type
4.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccine (Recombinant) Price by Type
4.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccine (Recombinant) Sales by Application
5.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Application
5.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application
5.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccine (Recombinant) Market Size by Type
6.1.1 North America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccine (Recombinant) Market Size by Application
6.2.1 North America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccine (Recombinant) Market Size by Country
6.3.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccine (Recombinant) Market Size by Type
7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccine (Recombinant) Market Size by Application
7.2.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccine (Recombinant) Market Size by Country
7.3.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Type
9.1.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Application
9.2.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Country
9.3.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Dynavax Technologies
11.4.1 Dynavax Technologies Corporation Information
11.4.2 Dynavax Technologies Overview
11.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dynavax Technologies Recent Developments
11.5 LG Life Sciences
11.5.1 LG Life Sciences Corporation Information
11.5.2 LG Life Sciences Overview
11.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LG Life Sciences Recent Developments
11.6 KM Biologics
11.6.1 KM Biologics Corporation Information
11.6.2 KM Biologics Overview
11.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 KM Biologics Recent Developments
11.7 Shenzhen Kangtai Biological Products
11.7.1 Shenzhen Kangtai Biological Products Corporation Information
11.7.2 Shenzhen Kangtai Biological Products Overview
11.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shenzhen Kangtai Biological Products Recent Developments
11.8 Serum Institute
11.8.1 Serum Institute Corporation Information
11.8.2 Serum Institute Overview
11.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
12.2 Hepatitis B Vaccine (Recombinant) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccine (Recombinant) Production Mode & Process
12.4 Hepatitis B Vaccine (Recombinant) Sales and Marketing
12.4.1 Hepatitis B Vaccine (Recombinant) Sales Channels
12.4.2 Hepatitis B Vaccine (Recombinant) Distributors
12.5 Hepatitis B Vaccine (Recombinant) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccine (Recombinant) Industry Trends
13.2 Hepatitis B Vaccine (Recombinant) Market Drivers
13.3 Hepatitis B Vaccine (Recombinant) Market Challenges
13.4 Hepatitis B Vaccine (Recombinant) Market Restraints
14 Key Findings in The Global Hepatitis B Vaccine (Recombinant) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10mcg/0.5ml
Table 3. Major Manufacturers of 10mcg/ml
Table 4. Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Hepatitis B Vaccine (Recombinant) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022) & (K Units)
Table 7. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2017-2022)
Table 8. Global Hepatitis B Vaccine (Recombinant) Sales by Region (2023-2028) & (K Units)
Table 9. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2023-2028)
Table 10. Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2017-2022)
Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2023-2028)
Table 14. Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers (2017-2022)
Table 16. Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2017-2022)
Table 18. Hepatitis B Vaccine (Recombinant) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Hepatitis B Vaccine (Recombinant) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2021)
Table 21. Hepatitis B Vaccine (Recombinant) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepatitis B Vaccine (Recombinant) Product Offered
Table 23. Date of Manufacturers Enter into Hepatitis B Vaccine (Recombinant) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 26. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 27. Global Hepatitis B Vaccine (Recombinant) Sales Share by Type (2017-2022)
Table 28. Global Hepatitis B Vaccine (Recombinant) Sales Share by Type (2023-2028)
Table 29. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2017-2022)
Table 32. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2023-2028)
Table 33. Hepatitis B Vaccine (Recombinant) Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 36. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 37. Global Hepatitis B Vaccine (Recombinant) Sales Share by Application (2017-2022)
Table 38. Global Hepatitis B Vaccine (Recombinant) Sales Share by Application (2023-2028)
Table 39. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Application (2017-2022)
Table 42. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Application (2023-2028)
Table 43. Hepatitis B Vaccine (Recombinant) Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 46. North America Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 47. North America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 50. North America Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 51. North America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 54. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2023-2028) & (K Units)
Table 55. North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 58. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 59. Europe Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 62. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 63. Europe Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 66. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2023-2028) & (K Units)
Table 67. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2023-2028) & (US$ Million)
Table 105. GSK Corporation Information
Table 106. GSK Description and Major Businesses
Table 107. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. GSK Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GSK Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Merck Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Recent Developments
Table 115. Sanofi Pasteur Corporation Information
Table 116. Sanofi Pasteur Description and Major Businesses
Table 117. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Pasteur Recent Developments
Table 120. Dynavax Technologies Corporation Information
Table 121. Dynavax Technologies Description and Major Businesses
Table 122. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Dynavax Technologies Recent Developments
Table 125. LG Life Sciences Corporation Information
Table 126. LG Life Sciences Description and Major Businesses
Table 127. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. LG Life Sciences Recent Developments
Table 130. KM Biologics Corporation Information
Table 131. KM Biologics Description and Major Businesses
Table 132. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. KM Biologics Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. KM Biologics Recent Developments
Table 135. Shenzhen Kangtai Biological Products Corporation Information
Table 136. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 137. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Shenzhen Kangtai Biological Products Recent Developments
Table 140. Serum Institute Corporation Information
Table 141. Serum Institute Description and Major Businesses
Table 142. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Serum Institute Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Serum Institute Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Hepatitis B Vaccine (Recombinant) Distributors List
Table 148. Hepatitis B Vaccine (Recombinant) Customers List
Table 149. Hepatitis B Vaccine (Recombinant) Market Trends
Table 150. Hepatitis B Vaccine (Recombinant) Market Drivers
Table 151. Hepatitis B Vaccine (Recombinant) Market Challenges
Table 152. Hepatitis B Vaccine (Recombinant) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccine (Recombinant) Product Picture
Figure 3. Global Hepatitis B Vaccine (Recombinant) Market Share by Type in 2021 & 2028
Figure 3. 10mcg/0.5ml Product Picture
Figure 4. 10mcg/ml Product Picture
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Share by Application in 2021 & 2028
Figure 6. Newborn
Figure 7. Adult
Figure 8. Hepatitis B Vaccine (Recombinant) Report Years Considered
Figure 9. Global Hepatitis B Vaccine (Recombinant) Sales 2017-2028 (K Units)
Figure 10. Global Hepatitis B Vaccine (Recombinant) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Hepatitis B Vaccine (Recombinant) Revenue 2017-2028 (US$ Million)
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2017-2022)
Figure 14. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2023-2028)
Figure 15. North America Hepatitis B Vaccine (Recombinant) Sales YoY (2017-2028) & (K Units)
Figure 16. North America Hepatitis B Vaccine (Recombinant) Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Hepatitis B Vaccine (Recombinant) Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Hepatitis B Vaccine (Recombinant) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Hepatitis B Vaccine (Recombinant) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Hepatitis B Vaccine (Recombinant) Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Hepatitis B Vaccine (Recombinant) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Hepatitis B Vaccine (Recombinant) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Hepatitis B Vaccine (Recombinant) in the World: Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2021
Figure 27. Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2028)
Figure 29. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2028)
Figure 30. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2028)
Figure 31. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2017-2028)
Figure 32. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2028)
Figure 33. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2028)
Figure 34. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2028)
Figure 35. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2017-2028)
Figure 36. North America Hepatitis B Vaccine (Recombinant) Sales Share by Country (2017-2028)
Figure 37. North America Hepatitis B Vaccine (Recombinant) Revenue Share by Country (2017-2028)
Figure 38. U.S. Hepatitis B Vaccine (Recombinant) Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Hepatitis B Vaccine (Recombinant) Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2028)
Figure 41. Europe Hepatitis B Vaccine (Recombinant) Rev

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs